WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| skeletal system development | ||
| transforming growth factor beta receptor signaling pathway | ||
| transforming growth factor beta receptor signaling pathway | ||
| negative regulation of peptidase activity |
|
|
| negative regulation of transforming growth factor beta receptor signaling pathway |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular space | ||
| extracellular space |
| GO Term | Evidence Code | PMID |
|---|---|---|
| serine-type endopeptidase inhibitor activity | ||
| protein binding | ||
| receptor antagonist activity | ||
| receptor antagonist activity | ||
| transforming growth factor beta binding |
| InterPro |
|---|
| Elafin-like superfamily |
| Immunoglobulin I-set |
| Immunoglobulin subtype 2 |
| Immunoglobulin subtype |
| Immunoglobulin-like domain superfamily |
| Immunoglobulin-like domain |
| Immunoglobulin-like fold |
| Kazal domain superfamily |
| Kazal domain |
| Netrin domain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026